"Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
Descriptor ID |
D009369
|
MeSH Number(s) |
C04
|
Concept/Terms |
Neoplasms- Neoplasms
- Neoplasia
- Neoplasias
- Neoplasm
- Tumors
- Tumor
Cancer- Cancer
- Cancers
- Malignant Neoplasms
- Malignant Neoplasm
- Neoplasm, Malignant
- Neoplasms, Malignant
- Malignancy
- Malignancies
Benign Neoplasms- Benign Neoplasms
- Neoplasms, Benign
- Benign Neoplasm
- Neoplasm, Benign
|
Below are MeSH descriptors whose meaning is more general than "Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Neoplasms".
This graph shows the total number of publications written about "Neoplasms" by people in this website by year, and whether "Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 7 | 4 | 11 |
1996 | 7 | 2 | 9 |
1997 | 13 | 0 | 13 |
1998 | 16 | 2 | 18 |
1999 | 8 | 6 | 14 |
2000 | 6 | 1 | 7 |
2001 | 10 | 4 | 14 |
2002 | 20 | 8 | 28 |
2003 | 25 | 10 | 35 |
2004 | 23 | 9 | 32 |
2005 | 33 | 7 | 40 |
2006 | 22 | 4 | 26 |
2007 | 32 | 7 | 39 |
2008 | 33 | 17 | 50 |
2009 | 49 | 5 | 54 |
2010 | 55 | 13 | 68 |
2011 | 47 | 14 | 61 |
2012 | 52 | 13 | 65 |
2013 | 65 | 14 | 79 |
2014 | 93 | 18 | 111 |
2015 | 68 | 12 | 80 |
2016 | 67 | 11 | 78 |
2017 | 100 | 15 | 115 |
2018 | 101 | 13 | 114 |
2019 | 78 | 11 | 89 |
2020 | 111 | 14 | 125 |
2021 | 108 | 9 | 117 |
2022 | 104 | 2 | 106 |
2023 | 101 | 5 | 106 |
2024 | 82 | 29 | 111 |
2025 | 35 | 2 | 37 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasms" by people in Profiles.
-
Immune checkpoint inhibitors-associated vasculitis: a heterogeneous condition with possible severe disease course. Rheumatology (Oxford). 2025 Jun 01; 64(6):3685-3690.
-
Is Less More? Maximizing Outcomes by Tailoring Treatments to Patients: Oncofertility and Oncomenopause. Am Soc Clin Oncol Educ Book. 2025 Jun; 45(3):e481126.
-
Update on Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome. Clin Cancer Res. 2025 May 15; 31(10):1831-1840.
-
Computational modeling of cancer cell metabolism along the catabolic-anabolic axes. NPJ Syst Biol Appl. 2025 May 10; 11(1):46.
-
Pediatric Malignant Tumors in Malawi: A Diagnostic Report From the Kamuzu Central Hospital Pathology Laboratory 2011-2020. Pediatr Blood Cancer. 2025 Jul; 72(7):e31669.
-
Management and Outcomes of Clostridioides difficile Infection in Patients on Immune Checkpoint Inhibitors. J Natl Compr Canc Netw. 2025 05; 23(5):147-155.
-
A framework-based guide for adapting and implementing primary care-based pediatric interventions to the pediatric oncology setting: HPV PROTECT as an exemplar. Cancer. 2025 May 01; 131(9):e35857.
-
Childbirth after cancer among 42?896 male adolescents and young adults: a population-based study. J Natl Cancer Inst. 2025 May 01; 117(5):1008-1017.
-
Phase I Trial of Selinexor in Pediatric Recurrent/Refractory Solid and CNS Tumors (ADVL1414): A Children's Oncology Group Phase I Consortium Trial. Clin Cancer Res. 2025 May 01; 31(9):1587-1595.
-
Temporal trends of subsequent central nervous system malignancies among survivors of childhood cancer. J Natl Cancer Inst. 2025 May 01; 117(5):1036-1045.